AMYLIN PHARMACEUTICALS INC (AMLN) [Rocket]

Date Filed

Type

Description

08/10/2012

ROWLAND LLOYD A (VP, Chief Compliance Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 412 shares @ $31, valued at $12.8k
Disposed of 35,014 shares @ $31, valued at $1.1M
Disposed of 473 shares @ $31, valued at $14.7k
Disposed of 3,192 shares @ $31, valued at $98.9k
Disposed of 6,614 shares @ $31, valued at $205k
Disposed of 1,360 shares @ $31, valued at $42.2k
Disposed of 6,250 options to buy @ $9.02, valued at $56.4k
Disposed of 5,000 options to buy @ $15.03, valued at $75.2k
Disposed of 7,802 options to buy @ $16.02, valued at $125k
Disposed of 5,251 options to buy @ $16.54, valued at $86.9k
Disposed of 7,081 options to buy @ $18.01, valued at $127.5k

08/10/2012

FOLETTA MARK G (SVP, CFO) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Acquired 64,702 shares @ $31, valued at $2M
Unknown transaction of 8,255 shares @ $31, valued at $255.9k
Unknown transaction of 65,115 shares @ $31, valued at $2M
Disposed of 64,702 shares @ $31, valued at $2M
Unknown transaction of 453 shares @ $31, valued at $14k
Unknown transaction of 3,415 shares @ $31, valued at $105.9k
Unknown transaction of 5,085 shares @ $31, valued at $157.6k
Unknown transaction of 2,889 shares @ $31, valued at $89.6k
Unknown transaction of 110 shares @ $31, valued at $3.4k
Disposed of 3,752 options to buy @ $9.02, valued at $33.8k
Disposed of 9,157 options to buy @ $15.03, valued at $137.6k

08/10/2012

BRADBURY DANIEL (President & Chief Executive Of) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Acquired 215,526 shares @ $31, valued at $6.7M
Disposed of 215,526 shares @ $31, valued at $6.7M
Unknown transaction of 94,618 shares @ $31, valued at $2.9M
Unknown transaction of 3,327 shares @ $31, valued at $103.1k
Unknown transaction of 42,897 shares @ $31, valued at $1.3M
Unknown transaction of 453 shares @ $31, valued at $14k
Unknown transaction of 13,003 shares @ $31, valued at $403.1k
Unknown transaction of 3,455 shares @ $31, valued at $107.1k
Unknown transaction of 4,519 shares @ $31, valued at $140.1k
Unknown transaction of 36,931 shares @ $31, valued at $1.1M
Unknown transaction of 9,463 shares @ $31, valued at $293.4k

08/10/2012

Lloyd Marcea Bland (SVP, Chief Administrative Offi) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 62,057 shares @ $31, valued at $1.9M
Disposed of 412 shares @ $31, valued at $12.8k
Disposed of 926 shares @ $31, valued at $28.7k
Disposed of 1,161 shares @ $31, valued at $36k
Disposed of 6,614 shares @ $31, valued at $205k
Disposed of 1,360 shares @ $31, valued at $42.2k
Disposed of shares @ $31, valued at $12.4
Disposed of 5,046 options to buy @ $9.02, valued at $45.5k
Disposed of 7,407 options to buy @ $15.03, valued at $111.3k
Disposed of 8,965 options to buy @ $16.02, valued at $143.6k
Disposed of 6,331 options to buy @ $18.01, valued at $114k

08/10/2012

LEONHARDT HARRY J (SVP, Legal, Compl & Corp Secty) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 32,345 shares @ $31, valued at $1M
Disposed of 6,361 shares @ $31, valued at $197.2k
Disposed of 727 shares @ $31, valued at $22.5k
Disposed of 3,159 shares @ $31, valued at $97.9k
Disposed of 4,227 shares @ $31, valued at $131k
Disposed of 7,814 options to buy @ $9.02, valued at $70.5k
Disposed of 8,614 options to buy @ $15.03, valued at $129.5k
Disposed of 9,552 options to buy @ $16.02, valued at $153k
Disposed of 6,437 options to buy @ $18.01, valued at $115.9k
Disposed of 1,253 options to buy @ $24.87, valued at $31.2k
Unknown transaction of 8,360 options to buy @ $47.83, valued at $399.9k

08/10/2012

Marshall Paul (SVP, Operations) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 31,723 shares @ $31, valued at $983.4k
Disposed of 1,632 shares @ $31, valued at $50.6k
Disposed of 473 shares @ $31, valued at $14.7k
Disposed of 4,984 shares @ $31, valued at $154.5k
Disposed of 2,990 shares @ $31, valued at $92.7k
Disposed of 5,597 options to buy @ $9.02, valued at $50.5k
Disposed of 11,069 options to buy @ $10.53, valued at $116.6k
Disposed of 7,553 options to buy @ $16.02, valued at $121k
Disposed of 6,904 options to buy @ $18.01, valued at $124.3k
Disposed of 7,145 options to buy @ $24.87, valued at $177.7k
Unknown transaction of 10,596 options to buy @ $37.75, valued at $400k

08/10/2012

Mihalik Vincent P (SVP, Chief Commercial Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 39,917 shares @ $31, valued at $1.2M
Disposed of 885 shares @ $31, valued at $27.4k
Disposed of 453 shares @ $31, valued at $14k
Disposed of 1,799 shares @ $31, valued at $55.8k
Disposed of 1,360 shares @ $31, valued at $42.2k
Disposed of 25,486 options to buy @ $13.05, valued at $332.6k
Disposed of 6,407 options to buy @ $15.03, valued at $96.3k
Disposed of 7,021 options to buy @ $16.02, valued at $112.5k
Disposed of 6,032 options to buy @ $18.01, valued at $108.6k
Disposed of 34,514 options to buy @ $13.05, valued at $450.4k
Disposed of 33,593 options to buy @ $15.03, valued at $504.9k

08/10/2012

Weyer Christian (SVP, Research & Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 33,195 shares @ $31, valued at $1M
Disposed of 1,012 shares @ $31, valued at $31.4k
Disposed of 453 shares @ $31, valued at $14k
Disposed of 886 shares @ $31, valued at $27.5k
Disposed of 359 shares @ $31, valued at $11.1k
Disposed of 4,815 shares @ $31, valued at $149.3k
Disposed of 3,159 shares @ $31, valued at $97.9k
Disposed of 6,252 options to buy @ $9.02, valued at $56.4k
Disposed of 11,973 options to buy @ $15.03, valued at $180k
Disposed of 6,242 options to buy @ $16.02, valued at $100k
Disposed of 2,633 options to buy @ $16.54, valued at $43.5k

08/10/2012

KOLTERMAN ORVILLE G (SVP, Chief Medical Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Acquired 71,349 shares @ $31, valued at $2.2M
Disposed of 71,349 shares @ $31, valued at $2.2M
Unknown transaction of 192,146 shares @ $31, valued at $6M
Unknown transaction of 415 shares @ $31, valued at $12.9k
Unknown transaction of 12,767 shares @ $31, valued at $395.8k
Unknown transaction of 4,984 shares @ $31, valued at $154.5k
Unknown transaction of 2,990 shares @ $31, valued at $92.7k
Disposed of 5,219 options to buy @ $15.03, valued at $78.4k
Disposed of 7,901 options to buy @ $16.02, valued at $126.6k
Disposed of 6,162 options to buy @ $16.54, valued at $101.9k
Disposed of 6,644 options to buy @ $18.01, valued at $119.7k

08/10/2012

Gergen Mark J (SVP, Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Unknown transaction of 64,338 shares @ $31, valued at $2M
Unknown transaction of 412 shares @ $31, valued at $12.8k
Acquired 53,181 shares @ $31, valued at $1.6M
Disposed of 53,181 shares @ $31, valued at $1.6M
Unknown transaction of 2,136 shares @ $31, valued at $66.2k
Unknown transaction of 473 shares @ $31, valued at $14.7k
Unknown transaction of 6,614 shares @ $31, valued at $205k
Unknown transaction of 1,360 shares @ $31, valued at $42.2k
Disposed of 3,439 options to buy @ $9.02, valued at $31k
Disposed of 7,533 options to buy @ $15.03, valued at $113.2k
Disposed of 8,379 options to buy @ $16.02, valued at $134.2k

08/10/2012

BECK TERESA (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 8,000 shares @ $31, valued at $248k
Disposed of 20,000 options to buy @ $11.68, valued at $233.6k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 20,000 options to buy @ $27.3, valued at $546k
Unknown transaction of 12,000 options to buy @ $31.77, valued at $381.2k
Unknown transaction of 20,000 options to buy @ $37.18, valued at $743.6k
Unknown transaction of 12,000 options to buy @ $44.64, valued at $535.7k
Disposed of 11,573 options to buy @ $31, valued at $358.8k
Disposed of 11,021 options to buy @ $31, valued at $341.7k
Disposed of 3,000 options to buy @ $31, valued at $93k

08/10/2012

ADAMS ADRIAN (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 10,800 shares @ $31, valued at $334.8k
Disposed of 10,200 shares @ $31, valued at $316.2k
Disposed of 20,000 options to buy @ $11.68, valued at $233.6k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 20,000 options to buy @ $27.3, valued at $546k
Unknown transaction of 12,000 options to buy @ $31.77, valued at $381.2k
Unknown transaction of 20,000 options to buy @ $46.58, valued at $931.6k

08/10/2012

EASTHAM KARIN (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 6,000 shares @ $31, valued at $186k
Disposed of 20,000 options to buy @ $11.68, valued at $233.6k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 20,000 options to buy @ $27.3, valued at $546k
Disposed of 20,000 options to buy @ $30.15, valued at $603k
Unknown transaction of 12,000 options to buy @ $31.77, valued at $381.2k
Unknown transaction of 12,000 options to buy @ $41.34, valued at $496.1k
Unknown transaction of 12,000 options to buy @ $44.64, valued at $535.7k
Disposed of 11,971 options to buy @ $31, valued at $371.1k
Disposed of 3,273 options to buy @ $31, valued at $101.5k

08/10/2012

GAVIN JAMES R III (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 4,580 shares @ $31, valued at $142k
Disposed of 20,000 options to buy @ $11.68, valued at $233.6k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 20,000 options to buy @ $27.3, valued at $546k
Unknown transaction of 12,000 options to buy @ $31.77, valued at $381.2k
Unknown transaction of 12,000 options to buy @ $41.34, valued at $496.1k
Unknown transaction of 12,000 options to buy @ $44.64, valued at $535.7k
Disposed of 6,173 options to buy @ $31, valued at $191.4k
Disposed of 4,015 options to buy @ $31, valued at $124.5k
Disposed of 3,000 options to buy @ $31, valued at $93k

08/10/2012

SULLIVAN JOSEPH P (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 6,000 shares @ $31, valued at $186k
Disposed of 20,000 options to buy @ $11.68, valued at $233.6k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 12,000 options to buy @ $16.23, valued at $194.8k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 12,000 options to buy @ $22.89, valued at $274.7k
Disposed of 20,000 options to buy @ $27.3, valued at $546k
Disposed of 20,000 options to buy @ $28.6, valued at $572k
Unknown transaction of 12,000 options to buy @ $31.77, valued at $381.2k
Unknown transaction of 12,000 options to buy @ $41.34, valued at $496.1k
Unknown transaction of 12,000 options to buy @ $44.64, valued at $535.7k

08/10/2012

SKYLER JAY S (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 98,286 shares @ $31, valued at $3M
Disposed of 23,000 shares @ $31, valued at $713k
Disposed of 201 shares @ $31, valued at $6.2k
Disposed of 6,675 shares @ $31, valued at $206.9k
Disposed of 20,000 shares @ $31, valued at $620k
Disposed of 20,000 options to buy @ $11.68, valued at $233.6k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 12,000 options to buy @ $16.23, valued at $194.8k
Disposed of 12,000 options to buy @ $19.24, valued at $230.9k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 12,000 options to buy @ $22.89, valued at $274.7k

08/10/2012

DENNER ALEXANDER J (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 9,057 shares @ $31, valued at $280.8k
Disposed of 1,104 shares @ $31, valued at $34.2k
Disposed of 30,000 options to buy @ $11.26, valued at $337.8k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 20,000 options to buy @ $27.3, valued at $546k

08/10/2012

Costa Paulo F (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 24,933 shares @ $31, valued at $772.9k
Disposed of 1,067 shares @ $31, valued at $33.1k
Disposed of 30,000 options to buy @ $11.26, valued at $337.8k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 20,000 options to buy @ $27.3, valued at $546k

08/10/2012

BEHRENS M KATHLEEN (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed of 6,000 shares @ $31, valued at $186k
Disposed of 30,000 options to buy @ $11.26, valued at $337.8k
Disposed of 20,000 options to buy @ $13.18, valued at $263.6k
Disposed of 20,000 options to buy @ $21.52, valued at $430.4k
Disposed of 20,000 options to buy @ $27.3, valued at $546k

07/26/2012

Weyer Christian (SVP, Research & Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Granted 39 shares @ $14.62, valued at $570.2

07/26/2012

ROWLAND LLOYD A (VP, Chief Compliance Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Granted 823 shares @ $14.62, valued at $12k

07/26/2012

Mihalik Vincent P (SVP, Chief Commercial Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Granted 890 shares @ $14.62, valued at $13k

07/26/2012

KOLTERMAN ORVILLE G (SVP, Chief Medical Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Granted 1,376 shares @ $14.62, valued at $20.1k
Paid exercise price by delivering 5,079 shares @ $30.795, valued at $156.4k
Paid exercise price by delivering 3,739 shares @ $30.795, valued at $115.1k
Paid exercise price by delivering 2,797 shares @ $30.795, valued at $86.1k
Paid exercise price by delivering 1,777 shares @ $30.795, valued at $54.7k
Exercised 7,209 options to buy @ $11.95, valued at $86.1k
Exercised 13,091 options to buy @ $11.95, valued at $156.4k

07/26/2012

Gergen Mark J (SVP, Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Granted 936 shares @ $14.62, valued at $13.7k

07/26/2012

FOLETTA MARK G (SVP, CFO) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Granted 880 shares @ $14.62, valued at $12.9k

07/26/2012

BRADBURY DANIEL (President & Chief Executive Of) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Paid exercise price by delivering 10,703 shares @ $30.795, valued at $329.6k
Paid exercise price by delivering 7,879 shares @ $30.795, valued at $242.6k
Paid exercise price by delivering 3,266 shares @ $30.795, valued at $100.6k
Paid exercise price by delivering 2,404 shares @ $30.795, valued at $74k
Exercised 8,418 options to buy @ $11.95, valued at $100.6k
Exercised 27,582 options to buy @ $11.95, valued at $329.6k

07/03/2012

BECK TERESA (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Granted 610 options to buy @ $30.7277, valued at $18.8k

07/03/2012

SULLIVAN JOSEPH P (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Granted 549 options to buy @ $30.7277, valued at $16.9k

05/24/2012

GAVIN JAMES R III (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC

Txns:

Disposed/sold 3,000 shares @ $0
Granted 3,000 options to buy @ $0